|
|
末期肾病血瘀证患者与动脉硬化的关系
|
Abstract:
探讨末期肾病接受长期血液透析的病患族群，其血瘀证表现与动脉重塑的关联性。方法：69位血液透析病患，分为血瘀证组40例及非血瘀证组29例，比较、记录的项目包括心血管疾病病史及其危险因子，并以脉波传导速度做为动脉硬化的指标、以足踝–肱动脉血压比做为动脉粥状硬化的指标。结果：在长期血液透析的病患族群，血瘀证与冠心病(p < 0.0001)及糖尿病(p = 0.018)有显着相关；血瘀证组平均年龄较高(p = 0.004)；血瘀证组较非血瘀证组，有较高的脉波传导速度(p < 0.0001)、收缩压(p = 0.019)及脉搏压(p = 0.004)；而在其它心血管疾病危险因子，两组无显着差异。进一步以logistic
| [1] | 皮持衡, 谢胜. 慢性肾功能衰竭血瘀病机探析[J]. 北京中医, 1997, 5: 989. |
| [2] | 王缨, 李国贤. 慢性肾衰竭患者血液流变学指标及血液黏滞综合征与血瘀证关系的研究[J]. 中国中西医结合肾病杂志, 2003, 4(2): 92-95. |
| [3] | 屈凯, 王天芳, 赵燕等. 基于专家咨询问卷调查的慢性肾功能衰竭常见中医证候要素的研究[J]. 中西医结合学报, 2010, 8(12): 1147-1152. |
| [4] | 陈维养. 陈可冀医学选集——七十初度[M]. 北京: 北京大学医学出版社, 2002: 304-348. |
| [5] | R. N. Foley, P. S. Parfrey and M. J. Sarnak. Clinical epidemiology of cardiovascular disease in chronic renal failure. American Journal of Kidney Disease, 1998, 32(5): S112-S119. |
| [6] | G. M. London, S. J. Marchais, A. P. Guerin, et al. Arterial structure and function in end-stage renal disease. Nephrology Dialysis Transplantation, 2002, 17: 1713-1724. |
| [7] | A. P. Guerin, J. Blacher, B. Pannier, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation, 2001, 103: 987-992. |
| [8] | P. G. Greenland, J. Abrams, G. P. Aurigemma, et al. Prevention Conference V-Beyond secondary prevention: Identifying the high risk patients for primary prevention, noninvasive tests for atherosclerosis burden. Circulation, 2000, 101: 16-22. |
| [9] | 中国中西医结合研究会第二次全国活血化瘀研究学术会议, 血瘀证诊断标准[J]. 中西医结合杂志, 1987, 7(3): 129. |
| [10] | 高铸烨, 张京春, 徐皓等. 用复杂网络挖掘分析冠心病证候–治法–中药关系[J]. 中西医结合学报, 2010, 8(3): 238-243. |
| [11] | 杨峰, 方淑媛. 应用活血化瘀法治疗糖尿病与血液流变学之关系的临床观察[J]. 中医函授通讯, 1994, 2: 38-39. |
| [12] | I. H. De Boer, T. C. Rue, Y. N. Hall, et al. Temporal trend in the prevalence of diabetic kidney disease in the United States. Journal of the American Medical Association, 2011, 305(24): 2532- 2539 |
| [13] | R. A. Wolfe, V. B. Ashby, E. L. Milford, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New England Journal of Medicine, 1999, 341: 1725-1730. |
| [14] | 陈可冀, 张之南, 梁子钧等. 血瘀证与活血化瘀研究[M]. 台北: 知音出版社, 1999: 391-397. |
| [15] | 赵燕. 脾肾两虚和瘀血痰浊与衰老机理的关系探要[J]. 中医药学, 2003, 21(5): 783. |
| [16] | 谷万里, 史载祥, 余云旭等. 原发性高血压的中医证型特征[J]. 中西医结合学报, 2010, 8(9): 842-847. |
| [17] | B. I. Levy, G. Ambrosio, A. R. Pries and H. A. J. Struijker- Boudier. Microcirculation in hypertension—A new target for treatment? Circulation, 2001, 104(6): 735-740. |
| [18] | M. E. Safar, B. I. Levy and H. A. J. Struijker-Boudier. Current perspectives on arterial stiffness and pulse pressure in hyper-tension and cardiovascular disease. Circulation, 2003, 107(22): 2864- 2869. |
| [19] | K. Scott, A. C. Mark, E. Mariko, et al. Endothe-lium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension, 2001, 38(5): 1049-1053. |
| [20] | D. Karine, B. Jacques, P. G. Alain, et al. Endothelin and cardiovascular remodeling in end-stage renal disease. Nephrology Dialysis Transplantation, 1998, 13(2): 375-383. |
